Jitao Wu

机构：Qingdao University, Yuhuangding Hospital · ORCID：0000-0002-7924-3923

发表论文 119 篇 · 总被引 2015 次 · h-index 23

代表论文

• First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 10)
• The Nerve-Induced Adipose Stem Cells Promote Nerve Repair in Stress Urinary Incontinence by Regulating Schwann Cell Repair Phenotype Conversion Through Activation of the Notch Pathway (2025 · Molecular Neurobiology · 被引 9)
• The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study (2025 · Cancer Immunology Immunotherapy · 被引 6)
• Efficacy and safety of botulinum toxin-A injection in the treatment of premature ejaculation: A systematic review and meta-analysis (2025 · PLoS ONE · 被引 3)
• HROB as a novel prognostic biomarker associated with tumor immunity in clear cell renal cell carcinoma: A comprehensive analysis integrating bulk sequencing (2024 · Asian Journal of Surgery · 被引 3)
• Disease burden of infertility in five East Asian countries from 1990 to 2021 and prediction for 2050: An analysis of the Global Burden of Disease study 2021 (2025 · PLoS ONE · 被引 2)